✦ LIBER ✦

S3-02-03: Results of a one-year randomized, placebo-controlled trial of dimebon for the treatment of mild to moderate Alzheimer’s disease

✍ Scribed by Rachelle S. Doody; Svetlana Gavrilova; Mary Sano; Ronald Thomas; Paul Aisen; Sergey Bachurin; Lynn Seely; David Hung

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Results from CONNECTION: A global, Phase

✍ Rachelle S. Doody; Pierre Tariot; Jeff Cummings; Bengt Winblad; Bryan Selby; And 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Saffron in the treatment of patients wit

✍ S. Akhondzadeh; M. Shafiee Sabet; M. H. Harirchian; M. Togha; H. Cheraghmakani; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB

An economic evaluation of donepezil in m

✍ Anders Wimo; Bengt Winblad; Vera Mastey; Peter Hertzman; Anders Haglund; Robert 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 177 KB

P4-337: Dimebon improves cognition, func

✍ Doody, Rachelle S.; Gavrilova, Svetlana; Thomas, Ronald; Aisen, Paul; Bachurin, 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 52 KB

A 22-week, multicenter, randomized, doub

✍ Shahin Akhondzadeh; Mehdi Shafiee Sabet; Mohammad Hossein Harirchian; Mansoreh T 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 161 KB

P4-334: Eighteen-month data from an open

✍ Cummings, Jeffrey; Doody, Rachelle; Gavrilova, Svetlana; Sano, Mary; Aisen, Paul 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 66 KB